相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。CRISPR screens reveal genetic determinants of PARP inhibitor sensitivity and resistance in prostate cancer
Takuya Tsujino et al.
NATURE COMMUNICATIONS (2023)
Testosterone suppression plus enzalutamide versus testosterone suppression plus standard antiandrogen therapy for metastatic hormone-sensitive prostate cancer (ENZAMET): an international, open-label, randomised, phase 3 trial
Christopher J Sweeney et al.
LANCET ONCOLOGY (2023)
TLK1-mediated MK5-S354 phosphorylation drives prostate cancer cell motility and may signify distinct pathologies
Md Imtiaz Khalil et al.
MOLECULAR ONCOLOGY (2022)
Tousled-like kinase 2 targets ASF1 histone chaperones through client mimicry
Bertrand Simon et al.
NATURE COMMUNICATIONS (2022)
Efficacy of PARP Inhibition in Metastatic Castration-resistant Prostate Cancer is Very Different with Non-BRCA DNA Repair Alterations: Reconstructing Prespecified Endpoints for Cohort B from the Phase 3 PROfound Trial of Olaparib
Konrad H. Stopsack
EUROPEAN UROLOGY (2021)
Clinical Efficacy of Enzalutamide vs Bicalutamide Combined With Androgen Deprivation Therapy in Men With Metastatic Hormone-Sensitive Prostate Cancer A Randomized Clinical Trial
Ulka N. Vaishampayan et al.
JAMA NETWORK OPEN (2021)
Effect of Chemotherapy on Overall Survival in Contemporary Metastatic Prostate Cancer Patients
Benedikt Hoeh et al.
FRONTIERS IN ONCOLOGY (2021)
Prostate cancer and PARP inhibitors: progress and challenges
Diego Teyssonneau et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
Interaction of TLK1 and AKTIP as a Potential Regulator of AKT Activation in Castration-Resistant Prostate Cancer Progression
Md Imtiaz Khalil et al.
PATHOPHYSIOLOGY (2021)
Role of the DNA damage response in prostate cancer formation, progression and treatment
Wenhao Zhang et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2020)
The TLK1/Nek1 axis contributes to mitochondrial integrity and apoptosis prevention via phosphorylation of VDAC1
Vibha Singh et al.
CELL CYCLE (2020)
Non-BRCA DNA Damage Repair Gene Alterations and Response to the PARP Inhibitor Rucaparib in Metastatic Castration-Resistant Prostate Cancer: Analysis From the Phase II TRITON2 Study
Wassim Abida et al.
CLINICAL CANCER RESEARCH (2020)
ERα-related chromothripsis enhances concordant gene transcription on chromosome 17q11.1-q24.1 in luminal breast cancer
Chun-Lin Lin et al.
BMC MEDICAL GENOMICS (2020)
Loss of CHD1 Promotes Heterogeneous Mechanisms of Resistance to AR-Targeted Therapy via Chromatin Dysregulation
Zeda Zhang et al.
CANCER CELL (2020)
Androgen receptor degraders over come common resistance mechanisms developed during prostate cancer treatment
Steven Kregel et al.
NEOPLASIA (2020)
Transcriptional profiling identifies an androgen receptor activity-low, stemness program associated with enzalutamide resistance
Joshi J. Alumkal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Checking NEKs: Overcoming a Bottleneck in Human Diseases
Andressa Peres de Oliveira et al.
MOLECULES (2020)
DNA Damage- But Not Enzalutamide-Induced Senescence in Prostate Cancer Promotes Senolytic Bcl-xL Inhibitor Sensitivity
Nicolas Malaquin et al.
CELLS (2020)
Comparative efficacy of apalutamide darolutamide and enzalutamide for treatment of non-metastatic castrate-resistant prostate cancer: A systematic review and network meta-analysis
Jatinder Kumar et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2020)
Generation of Phenothiazine with Potent Anti-TLK1 Activity for Prostate Cancer Therapy
Vibha Singh et al.
ISCIENCE (2020)
NEK1 Phosphorylation of YAP Promotes Its Stabilization and Transcriptional Output
Md Imtiaz Khalil et al.
CANCERS (2020)
The TLK1-Nek1 axis promotes prostate cancer progression
Vibha Singh et al.
CANCER LETTERS (2019)
Targeting the TLK1/NEK1 DDR axis with Thioridazine suppresses outgrowth of androgen independent prostate tumors
Vibha Singh et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
ARV-110: An oral androgen receptor PROTAC degrader for prostate cancer.
Taavi Neklesa et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
The antipsychotic chlorpromazine suppresses YAP signaling, stemness properties, and drug resistance in breast cancer cells
Chang-En Yang et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2019)
Targeting Nuclear Receptors with PROTAC degraders
John J. Flanagan et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2019)
Genomic correlates of clinical outcome in advanced prostate cancer
Wassim Abida et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
The Tousled-like kinases regulate genome and epigenome stability: implications in development and disease
Sandra Segura-Bayona et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2019)
The Role of Lineage Plasticity in Prostate Cancer Therapy Resistance
Himisha Beltran et al.
CLINICAL CANCER RESEARCH (2019)
Patterns of care and outcomes in small cell carcinoma of the prostate: A national cancer database analysis
April L. Metzger et al.
PROSTATE (2019)
N-Myc mediated epigenetic reprogramming drives lineage plasticity in advanced prostate cancer
Adeline Berger et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer
Mark P. Labrecque et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Clinical features of neuroendocrine prostate cancer
Vincenza Conteduca et al.
EUROPEAN JOURNAL OF CANCER (2019)
Activation of PP2A and Inhibition of mTOR Synergistically Reduce MYC Signaling and Decrease Tumor Growth in Pancreatic Ductal Adenocarcinoma
Brittany L. Allen-Petersen et al.
CANCER RESEARCH (2019)
Clinical and Genomic Characterization of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer: A Multi-institutional Prospective Study
Rahul Aggarwal et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
The Histone Chaperones ASF1 and CAF-1 Promote MMS22L-TONSL-Mediated Rad51 Loading ontossDNA during Homologous Recombination in Human Cells
Ting-Hsiang Huang et al.
MOLECULAR CELL (2018)
Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer
Maha Hussain et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Preserving salivary gland physiology against genotoxic damage - the Tousled way
G. Sunavala-Dossabhoy
ORAL DISEASES (2018)
Molecular basis of Tousled-Like Kinase 2 activation
Gulnahar B. Mortuza et al.
NATURE COMMUNICATIONS (2018)
Tousled-like kinases stabilize replication forks and show synthetic lethality with checkpoint and PARP inhibitors
Sung-Bau Lee et al.
SCIENCE ADVANCES (2018)
The Master Neural Transcription Factor BRN2 Is an Androgen Receptor-Suppressed Driver of Neuroendocrine Differentiation in Prostate Cancer
Jennifer L. Bishop et al.
CANCER DISCOVERY (2017)
Androgen-independent LNCaP cells are a subline of LNCaP cells with a more aggressive phenotype and androgen suppresses their growth by inducing cell cycle arrest at the G1 phase
Pan Yu et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2017)
FOXA2 is a sensitive and specific marker for small cell neuroendocrine carcinoma of the prostate
Jung Wook Park et al.
MODERN PATHOLOGY (2017)
Androgen receptor inhibitor-induced BRCAness and PARP inhibition are synthetically lethal for castration-resistant prostate cancer
Likun Li et al.
SCIENCE SIGNALING (2017)
Thioridazine enhances sensitivity to carboplatin in human head and neck cancer cells through downregulation of c-FLIP and Mcl-1 expression
Seung Un Seo et al.
CELL DEATH & DISEASE (2017)
Thioridazine has potent antitumor effects on lung cancer stem-like cells
Jiani Shen et al.
ONCOLOGY LETTERS (2017)
Transdifferentiation as a Mechanism of Treatment Resistance in a Mouse Model of Castration-Resistant Prostate Cancer
Min Zou et al.
CANCER DISCOVERY (2017)
Combining enzalutamide with PARP inhibitors: Pharmaceutically induced BRCAness
Timothy C. Thompson et al.
ONCOTARGET (2017)
Targeting DNA Damage Response in Prostate Cancer by Inhibiting Androgen Receptor-CDC6-ATR-Chk1 Signaling
Styliani Karanika et al.
CELL REPORTS (2017)
Androgen receptor inhibitor-induced BRCAness and PARP inhibition are synthetically lethal for castration-resistant prostate cancer
Likun Li et al.
SCIENCE SIGNALING (2017)
NEK1 kinase domain structure and its dynamic protein interactome after exposure to Cisplatin
Talita D. Melo-Hanchuk et al.
SCIENTIFIC REPORTS (2017)
Differential requirements for Tousled-like kinases 1 and 2 in mammalian development
Sandra Segura-Bayona et al.
CELL DEATH AND DIFFERENTIATION (2017)
Androgen Receptor Pathway-Independent Prostate Cancer Is Sustained through FGF Signaling
Eric G. Bluemn et al.
CANCER CELL (2017)
Identification of the proteome complement of humanTLK1 reveals it binds and phosphorylates NEK1 regulating its activity
Vibha Singh et al.
CELL CYCLE (2017)
The Anticancer Activity of the Old Neuroleptic Phenothiazine-type Drug Thioridazine
Gabriella Spengler et al.
ANTICANCER RESEARCH (2016)
TLK1B mediated phosphorylation of Rad9 regulates its nuclear/cytoplasmic localization and cell cycle checkpoint
Sanket Awate et al.
BMC MOLECULAR BIOLOGY (2016)
N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate Cancer
Etienne Dardenne et al.
CANCER CELL (2016)
TRIM24 Is an Oncogenic Transcriptional Activator in Prostate Cancer
Anna C. Groner et al.
CANCER CELL (2016)
Codelivery of thioridazine and doxorubicin using nanoparticles for effective breast cancer therapy
Xun Jin et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2016)
Androgen receptor targeted therapies in castration-resistant prostate cancer: Bench to clinic
Yusuke Imamura et al.
INTERNATIONAL JOURNAL OF UROLOGY (2016)
Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer
Himisha Beltran et al.
NATURE MEDICINE (2016)
Meta-analysis of 2,104 trios provides support for 10 new genes for intellectual disability
Stefan H. Lelieveld et al.
NATURE NEUROSCIENCE (2016)
Repurposing antipsychotics as glioblastoma therapeutics: Potentials and challenges
Jin-Ku Lee et al.
ONCOLOGY LETTERS (2016)
Comprehensive functional analysis of the tousled-like kinase 2 frequently amplified in aggressive luminal breast cancers
Jin-Ah Kim et al.
NATURE COMMUNICATIONS (2016)
Thioridazine Sensitizes Esophageal Carcinoma Cell Lines to Radiotherapy-Induced Apoptosis In Vitro and In Vivo
Hongxia Li et al.
MEDICAL SCIENCE MONITOR (2016)
ERG Activates the YAP1 Transcriptional Program and Induces the Development of Age-Related Prostate Tumors
Liem T. Nguyen et al.
CANCER CELL (2015)
The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities
Samuel Genheden et al.
EXPERT OPINION ON DRUG DISCOVERY (2015)
ATM Inhibition Potentiates Death of Androgen Receptor-inactivated Prostate Cancer Cells with Telomere Dysfunction
Vidyavathi Reddy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
The Hippo Pathway Effector YAP Regulates Motility, Invasion, and Castration-Resistant Growth of Prostate Cancer Cells
Lin Zhang et al.
MOLECULAR AND CELLULAR BIOLOGY (2015)
YAP1 and AR interactions contribute to the switch from androgen-dependent to castration-resistant growth in prostate cancer
Gamze Kuser-Abali et al.
NATURE COMMUNICATIONS (2015)
DNA damage response and prostate cancer: defects, regulation and therapeutic implications
S. Karanika et al.
ONCOGENE (2015)
Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer
Philip A. Watson et al.
NATURE REVIEWS CANCER (2015)
An update on enzalutamide in the treatment of prostate cancer
Axel S. Merseburger et al.
THERAPEUTIC ADVANCES IN UROLOGY (2015)
Proposed Morphologic Classification of Prostate Cancer With Neuroendocrine Differentiation
Jonathan I. Epstein et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2014)
Reduced Emergence of Isoniazid Resistance with Concurrent Use of Thioridazine against Acute Murine Tuberculosis
Noton K. Dutta et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Key regulators in prostate cancer identified by co-expression module analysis
Junfeng Jiang et al.
BMC GENOMICS (2014)
Key role of dual specificity kinase TTK in proliferation and survival of pancreatic cancer cells
B. P. Kaistha et al.
BRITISH JOURNAL OF CANCER (2014)
Aggressive Variants of Castration-Resistant Prostate Cancer
Himisha Beltran et al.
CLINICAL CANCER RESEARCH (2014)
Mechanisms of acquired resistance to androgen receptor targeting drugs in castration-resistant prostate cancer
David D. Chism et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2014)
Tousled-like kinases phosphorylate Asf1 to promote histone supply during DNA replication
Ilnaz M. Klimovskaia et al.
NATURE COMMUNICATIONS (2014)
Thioridazine inhibits angiogenesis and tumor growth by targeting the VEGFR-2/PI3K/mTOR pathway in ovarian cancer xenografts
Mi Sun Park et al.
ONCOTARGET (2014)
A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery
Yinghong Gao et al.
BIOCHEMICAL JOURNAL (2013)
Platinum-Based Chemotherapy for Variant Castrate-Resistant Prostate Cancer
Ana M. Aparicio et al.
CLINICAL CANCER RESEARCH (2013)
Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches
T. Karantanos et al.
ONCOGENE (2013)
Nek1 kinase associates with ATR-ATRIP and primes ATR for efficient DNA damage signaling
Shizhou Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
A Hormone-DNA Repair Circuit Governs the Response to Genotoxic Insult
Jonathan F. Goodwin et al.
CANCER DISCOVERY (2013)
Androgen Receptor Signaling Regulates DNA Repair in Prostate Cancers
William R. Polkinghorn et al.
CANCER DISCOVERY (2013)
Thioridazine induces apoptosis by targeting the PI3K/Akt/mTOR pathway in cervical and endometrial cancer cells
Sokbom Kang et al.
APOPTOSIS (2012)
Mitochondrial VDAC1: Function in Cell Life and Death and a Target for Cancer Therapy
V. Shoshan-Barmatz et al.
CURRENT MEDICINAL CHEMISTRY (2012)
Inactivation of ATM/ATR DNA Damage Checkpoint Promotes Androgen Induced Chromosomal Instability in Prostate Epithelial Cells
Yung-Tuen Chiu et al.
PLOS ONE (2012)
Phase II study of carboplatin and etoposide in patients with anaplastic progressive metastatic castration-resistant prostate cancer (mCRPC) with or without neuroendocrine differentiation: results of the French Genito-Urinary Tumor Group (GETUG) P01 trial
A. Flechon et al.
ANNALS OF ONCOLOGY (2011)
Reciprocal Feedback Regulation of PI3K and Androgen Receptor Signaling in PTEN-Deficient Prostate Cancer
Brett S. Carver et al.
CANCER CELL (2011)
Nek1 kinase functions in DNA damage response and checkpoint control through a pathway independent of ATM and ATR
Yumay Chen et al.
CELL CYCLE (2011)
Nek1 and TAZ Interact to Maintain Normal Levels of Polycystin 2
Hyungshin Yim et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
ERG gene rearrangements are common in prostatic small cell carcinomas
Tamara L. Lotan et al.
MODERN PATHOLOGY (2011)
Drug resistance in metastatic castration-resistant prostate cancer
Bostjan Seruga et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
The Expression of Tousled Kinases in CaP Cell Lines and Its Relation to Radiation Response and DSB Repair
Sharon Ronald et al.
PROSTATE (2011)
Molecular Characterization of Neuroendocrine Prostate Cancer and Identification of New Drug Targets
Himisha Beltran et al.
CANCER DISCOVERY (2011)
Integrative Genomic Profiling of Human Prostate Cancer
Barry S. Taylor et al.
CANCER CELL (2010)
Wnt signaling and its downstream target N-myc regulate basal progenitors in the developing neocortex
Atsushi Kuwahara et al.
DEVELOPMENT (2010)
Wnt-11 promotes neuroendocrine-like differentiation, survival and migration of prostate cancer cells
Pinar Uysal-Onganer et al.
MOLECULAR CANCER (2010)
Combining carboplatin and etoposide in docetaxel-pretreated patients with castration-resistant prostate cancer: a prospective study evaluating also neuroendocrine features
Y. Loriot et al.
ANNALS OF ONCOLOGY (2009)
TLK1B promotes repair of DSBs via its interaction with Rad9 and Asf1 Caroline Canfield, Justin Rains, and Arrigo De Benedetti
Caroline Canfield et al.
BMC MOLECULAR BIOLOGY (2009)
Tousled homolog, TLK1, binds and phosphorylates Rad9; TLK1 acts as a molecular chaperone in DNA repair
Gulshan Sunauala-Dossabhoy et al.
DNA REPAIR (2009)
Anti-androgens and androgen-depleting therapies in prostate cancer: new agents for an established target
Yu Chen et al.
LANCET ONCOLOGY (2009)
Behavioral adaptation in C. elegans produced by antipsychotic drugs requires serotonin and is associated with calcium signaling and calcineurin inhibition
Dallas R. Donohoe et al.
NEUROSCIENCE RESEARCH (2009)
Activation of β-Catenin in Mouse Prostate Causes HGPIN and Continuous Prostate Growth After Castration
Xiuping Yu et al.
PROSTATE (2009)
Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletion
William P. Harris et al.
NATURE CLINICAL PRACTICE UROLOGY (2009)
Maintenance of intratumoral androgens in metastatic prostate cancer: A mechanism for castration-resistant tumor growth
R. Bruce Montgomery et al.
CANCER RESEARCH (2008)
Never-in-mitosis related kinase 1 functions in DNA damage response and checkpoint control
Yumay Chen et al.
CELL CYCLE (2008)
Androgen receptor and growth factor signaling cross-talk in prostate cancer cells
Meng-Lei Zhu et al.
ENDOCRINE-RELATED CANCER (2008)
Discovery of antiandrogen activity of nonsteroidal scaffolds of marketed drugs
W. H. Bisson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Antipsychotic drugs disrupt normal development in Caenorhabditis elegans via additional mechanisms besides dopamine and serotonin receptors
Dallas R. Donohoe et al.
PHARMACOLOGICAL RESEARCH (2006)
Androgen receptor as a licensing factor for DNA replication in androgen-sensitive prostate cancer cells
Ivan V. Litvinov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Development of the VCaP androgen-independent model of prostate cancer
RD Loberg et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2006)
Nek1 shares structural and functional similarities with NIMA kinase
Erez Feige et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2006)
Direct, androgen receptor-mediated regulation of the FKBP5 gene via a distal enhancer element
JA Magee et al.
ENDOCRINOLOGY (2006)
The radioresistance kinase TLK1B protects the cells by promoting repair of double strand breaks
G Sunavala-Dossabhoy et al.
BMC MOLECULAR BIOLOGY (2005)
A human- and male-specific protocadherin that acts through the Wnt signaling pathway to induce neuroendocrine transdifferentiation of prostate cancer cells
XZ Yang et al.
CANCER RESEARCH (2005)
The C-elegans tousled-like kinase contributes to chromosome segregation as a substrate and regulator of the Aurora B kinase
ZB Han et al.
CURRENT BIOLOGY (2005)
The transcriptional coactivator Yes-associated protein drives p73 gene-target specificity in response to DNA damage
S Strano et al.
MOLECULAR CELL (2005)
Translation of the radioresistance kinase TLK1B is induced by γ-irradiation through activation of mTOR and phosphorylation of 4E-BP1 -: art. no. 1
G Sunavala-Dossabhoy et al.
BMC MOLECULAR BIOLOGY (2004)
Androgen receptor in prostate cancer
CA Heinlein et al.
ENDOCRINE REVIEWS (2004)
NIMA-related protein kinase 1 is involved early in the ionizing radiation-induced DNA damage response
R Polci et al.
CANCER RESEARCH (2004)
Androgen-independent prostate cancer is a heterogeneous group of diseases: Lessons from a rapid autopsy program
RB Shah et al.
CANCER RESEARCH (2004)
TLK1B is elevated with eIF4E overexpression in breast cancer
KS Norton et al.
JOURNAL OF SURGICAL RESEARCH (2004)
The C-elegans Tousled-like kinase (TLK-1) has an essential role in transcription
ZB Han et al.
CURRENT BIOLOGY (2003)
A dominant negative mutant of TLK1 causes chromosome missegregation and aneuploidy in normal breast epithelial cells
G Sunavala-Dossabhoy et al.
BMC CELL BIOLOGY (2003)
Tousled-like kinase functions with the chromatin assembly pathway regulating nuclear divisions
P Carrera et al.
GENES & DEVELOPMENT (2003)
Receptor protein tyrosine phosphatase alpha signaling is involved in androgen depletion-induced neuroendocrine differentiation of androgen-sensitive LNCaP human prostate cancer cells
XQ Zhang et al.
ONCOGENE (2003)
A translationally regulated Tousled kinase phosphorylates histone H3 and confers radioresistance when overexpressed
Y Li et al.
ONCOGENE (2001)
分享论文
